ID   ABL1_HUMAN              Reviewed;        1149 AA.
AC   P00519-2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 4.
DT   12-OCT-2022, entry version 276.
DE   RecName: Full=Isoform IB of Tyrosine-protein kinase ABL1;
DE            EC=2.7.10.2 {ECO:0000269|PubMed:20357770, ECO:0000269|PubMed:28428613};
DE   AltName: Full=Abelson murine leukemia viral oncogene homolog 1;
DE   AltName: Full=Abelson tyrosine-protein kinase 1;
DE   AltName: Full=Proto-oncogene c-Abl;
DE   AltName: Full=p150;
GN   Name=ABL1; Synonyms=ABL, JTK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IA), ALTERNATIVE SPLICING, CHROMOSOMAL
RP   TRANSLOCATION WITH BRC, AND VARIANT PRO-140.
RX   PubMed=3021337; DOI=10.1016/0092-8674(86)90450-2;
RA   Shtivelman E., Lifshitz B., Gale R.P., Roe B.A., Canaani E.;
RT   "Alternative splicing of RNAs transcribed from the human abl gene and from
RT   the bcr-abl fused gene.";
RL   Cell 47:277-284(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IA).
RC   TISSUE=Fibroblast;
RX   PubMed=2687768;
RA   Fainstein E., Einat M., Gokkel E., Marcelle C., Croce C.M., Gale R.P.,
RA   Canaani E.;
RT   "Nucleotide sequence analysis of human abl and bcr-abl cDNAs.";
RL   Oncogene 4:1477-1481(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS IA AND IB).
RC   TISSUE=Lung;
RX   PubMed=7665185; DOI=10.1006/geno.1995.1008;
RA   Chissoe S.L., Bodenteich A., Wang Y.-F., Wang Y.-P., Burian D.,
RA   Clifton S.W., Crabtree J., Freeman A., Iyer K., Jian L., Ma Y.,
RA   McLaury H.-J., Pan H.-Q., Sarhan O.H., Toth S., Wang Z., Zhang G.,
RA   Heisterkamp N., Groffen J., Roe B.A.;
RT   "Sequence and analysis of the human ABL gene, the BCR gene, and regions
RT   involved in the Philadelphia chromosomal translocation.";
RL   Genomics 27:67-82(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-706; PRO-852; SER-900
RP   AND LEU-972.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IB).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-40, AND SUBCELLULAR COMPONENT.
RX   PubMed=2825022; DOI=10.1038/330386a0;
RA   Fainstein E., Marcelle C., Rosner A., Canaani E., Gale R.P., Dreazen O.,
RA   Smith S.D., Croce C.M.;
RT   "A new fused transcript in Philadelphia chromosome positive acute
RT   lymphocytic leukaemia.";
RL   Nature 330:386-388(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 360-426.
RX   PubMed=6191223; DOI=10.1038/304167a0;
RA   Groffen J., Heisterkamp N., Reynolds F.H. Jr., Stephenson J.R.;
RT   "Homology between phosphotyrosine acceptor site of human c-abl and viral
RT   oncogene products.";
RL   Nature 304:167-169(1983).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 825-845.
RX   PubMed=7545908;
RA   Inokuchi K., Futaki M., Dan K., Nomura T.;
RT   "Sequence analysis of the mutation at codon 834 and the sequence variation
RT   of codon 837 of c-abl gene.";
RL   Leukemia 8:343-344(1994).
RN   [11]
RP   MYRISTOYLATION AT GLY-2 (ISOFORM IB).
RX   PubMed=2542016; DOI=10.1002/j.1460-2075.1989.tb03397.x;
RA   Jackson P., Baltimore D.;
RT   "N-terminal mutations activate the leukemogenic potential of the
RT   myristoylated form of c-abl.";
RL   EMBO J. 8:449-456(1989).
RN   [12]
RP   DOMAIN, AND DNA-BINDING.
RX   PubMed=2183353; DOI=10.1126/science.2183353;
RA   Kipreos E.T., Wang J.Y.;
RT   "Differential phosphorylation of c-Abl in cell cycle determined by cdc2
RT   kinase and phosphatase activity.";
RL   Science 248:217-220(1990).
RN   [13]
RP   FUNCTION.
RX   PubMed=9037071; DOI=10.1073/pnas.94.4.1437;
RA   Yuan Z.M., Huang Y., Ishiko T., Kharbanda S., Weichselbaum R., Kufe D.;
RT   "Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:1437-1440(1997).
RN   [14]
RP   INTERACTION WITH RIN1, AND FUNCTION.
RX   PubMed=9144171; DOI=10.1073/pnas.94.10.4954;
RA   Han L., Wong D., Dhaka A., Afar D.E.H., White M., Xie W., Herschman H.,
RA   Witte O., Colicelli J.;
RT   "Protein binding and signaling properties of RIN1 suggest a unique effector
RT   function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4954-4959(1997).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH RAD51.
RX   PubMed=9461559; DOI=10.1074/jbc.273.7.3799;
RA   Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Kharbanda S.,
RA   Wang R., Sung P., Shinohara A., Weichselbaum R., Kufe D.;
RT   "Regulation of Rad51 function by c-Abl in response to DNA damage.";
RL   J. Biol. Chem. 273:3799-3802(1998).
RN   [16]
RP   INTERACTION WITH INPPL1.
RX   PubMed=10194451;
RA   Wisniewski D., Strife A., Swendeman S., Erdjument-Bromage H., Geromanos S.,
RA   Kavanaugh W.M., Tempst P., Clarkson B.;
RT   "A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-
RT   phosphatase (SHIP2) is constitutively tyrosine phosphorylated and
RT   associated with src homologous and collagen gene (SHC) in chronic
RT   myelogenous leukemia progenitor cells.";
RL   Blood 93:2707-2720(1999).
RN   [17]
RP   FUNCTION, ACTIVITY REGULATION, AND INTERACTION WITH TP73.
RX   PubMed=10391250; DOI=10.1038/21697;
RA   Agami R., Blandino G., Oren M., Shaul Y.;
RT   "Interaction of c-Abl and p73alpha and their collaboration to induce
RT   apoptosis.";
RL   Nature 399:809-813(1999).
RN   [18]
RP   DNA-BINDING.
RX   PubMed=10325413; DOI=10.1093/nar/27.11.2265;
RA   David-Cordonnier M.H., Payet D., D'Halluin J.C., Waring M.J., Travers A.A.,
RA   Bailly C.;
RT   "The DNA-binding domain of human c-Abl tyrosine kinase promotes the
RT   interaction of a HMG chromosomal protein with DNA.";
RL   Nucleic Acids Res. 27:2265-2270(1999).
RN   [19]
RP   REVIEW ON FUNCTION.
RX   PubMed=11114745; DOI=10.1038/sj.onc.1203878;
RA   Wang J.Y.;
RT   "Regulation of cell death by the Abl tyrosine kinase.";
RL   Oncogene 19:5643-5650(2000).
RN   [20]
RP   INTERACTION WITH SORBS1.
RX   PubMed=11374898; DOI=10.1006/geno.2001.6541;
RA   Lin W.-H., Huang C.-J., Liu M.-W., Chang H.-M., Chen Y.-J., Tai T.-Y.,
RA   Chuang L.-M.;
RT   "Cloning, mapping, and characterization of the human sorbin and SH3 domain
RT   containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin
RT   signaling in the hepatoma cell line Hep3B.";
RL   Genomics 74:12-20(2001).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH RAD52.
RX   PubMed=12379650; DOI=10.1074/jbc.m208151200;
RA   Kitao H., Yuan Z.M.;
RT   "Regulation of ionizing radiation-induced Rad52 nuclear foci formation by
RT   c-Abl-mediated phosphorylation.";
RL   J. Biol. Chem. 277:48944-48948(2002).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH RAD9A.
RX   PubMed=11971963; DOI=10.1128/mcb.22.10.3292-3300.2002;
RA   Yoshida K., Komatsu K., Wang H.-G., Kufe D.;
RT   "c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in
RT   response to DNA damage.";
RL   Mol. Cell. Biol. 22:3292-3300(2002).
RN   [23]
RP   UBIQUITINATION.
RX   PubMed=12475393; DOI=10.1042/bj20021539;
RA   Soubeyran P., Barac A., Szymkiewicz I., Dikic I.;
RT   "Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.";
RL   Biochem. J. 370:29-34(2003).
RN   [24]
RP   FUNCTION.
RX   PubMed=12531427; DOI=10.1016/s0898-6568(02)00090-6;
RA   Sanguinetti A.R., Mastick C.C.;
RT   "c-Abl is required for oxidative stress-induced phosphorylation of
RT   caveolin-1 on tyrosine 14.";
RL   Cell. Signal. 15:289-298(2003).
RN   [25]
RP   FUNCTION.
RX   PubMed=12672821; DOI=10.1074/jbc.m301447200;
RA   Tani K., Sato S., Sukezane T., Kojima H., Hirose H., Hanafusa H.,
RA   Shishido T.;
RT   "Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian
RT   enabled (Mena) by c-Abl kinase.";
RL   J. Biol. Chem. 278:21685-21692(2003).
RN   [26]
RP   REVIEW ON FUNCTION.
RX   PubMed=12775773; DOI=10.1242/jcs.00622;
RA   Woodring P.J., Hunter T., Wang J.Y.;
RT   "Regulation of F-actin-dependent processes by the Abl family of tyrosine
RT   kinases.";
RL   J. Cell Sci. 116:2613-2626(2003).
RN   [27]
RP   INTERACTION WITH BCR.
RX   PubMed=15302586; DOI=10.1016/j.yexcr.2004.05.010;
RA   Laurent C.E., Smithgall T.E.;
RT   "The c-Fes tyrosine kinase cooperates with the breakpoint cluster region
RT   protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent
RT   manner.";
RL   Exp. Cell Res. 299:188-198(2004).
RN   [28]
RP   FUNCTION.
RX   PubMed=15556646; DOI=10.1016/j.febslet.2004.10.054;
RA   Grossmann A.H., Kolibaba K.S., Willis S.G., Corbin A.S., Langdon W.S.,
RA   Deininger M.W., Druker B.J.;
RT   "Catalytic domains of tyrosine kinases determine the phosphorylation sites
RT   within c-Cbl.";
RL   FEBS Lett. 577:555-562(2004).
RN   [29]
RP   FUNCTION.
RX   PubMed=15031292; DOI=10.1074/jbc.m311479200;
RA   Perkinton M.S., Standen C.L., Lau K.F., Kesavapany S., Byers H.L., Ward M.,
RA   McLoughlin D.M., Miller C.C.;
RT   "The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to
RT   stimulate Fe65/amyloid precursor protein nuclear signaling.";
RL   J. Biol. Chem. 279:22084-22091(2004).
RN   [30]
RP   REVIEW ON FUNCTION.
RX   PubMed=15686624; DOI=10.1038/sj.cr.7290261;
RA   Shaul Y., Ben-Yehoyada M.;
RT   "Role of c-Abl in the DNA damage stress response.";
RL   Cell Res. 15:33-35(2005).
RN   [31]
RP   FUNCTION.
RX   PubMed=15886098; DOI=10.1016/j.cub.2005.03.049;
RA   Hu H., Bliss J.M., Wang Y., Colicelli J.;
RT   "RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-
RT   cell adhesion and migration.";
RL   Curr. Biol. 15:815-823(2005).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH CASP9.
RX   PubMed=15657060; DOI=10.1074/jbc.m413787200;
RA   Raina D., Pandey P., Ahmad R., Bharti A., Ren J., Kharbanda S.,
RA   Weichselbaum R., Kufe D.;
RT   "c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic
RT   response to DNA damage.";
RL   J. Biol. Chem. 280:11147-11151(2005).
RN   [33]
RP   INTERACTION WITH YWHAB; YWHAE; YWHAG; YWHAH; SFN AND YWHAZ, PHOSPHORYLATION
RP   AT THR-735, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF THR-735.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-
RT   Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [35]
RP   ACETYLATION AT LYS-711, AND SUBCELLULAR LOCATION.
RX   PubMed=16648821; DOI=10.1038/sj.embor.7400700;
RA   di Bari M.G., Ciuffini L., Mingardi M., Testi R., Soddu S., Barila D.;
RT   "c-Abl acetylation by histone acetyltransferases regulates its nuclear-
RT   cytoplasmic localization.";
RL   EMBO Rep. 7:727-733(2006).
RN   [36]
RP   PHOSPHORYLATION AT TYR-70; TYR-115; TYR-128; TYR-139; TYR-172; TYR-185
RP   TYR-215; TYR-226 AND TYR-393, INTERACTION WITH HCK; LYN AND FYN, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16912036; DOI=10.1074/jbc.m605902200;
RA   Meyn M.A. III, Wilson M.B., Abdi F.A., Fahey N., Schiavone A.P., Wu J.,
RA   Hochrein J.M., Engen J.R., Smithgall T.E.;
RT   "Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate
RT   Bcr-Abl transforming activity.";
RL   J. Biol. Chem. 281:30907-30916(2006).
RN   [37]
RP   FUNCTION.
RX   PubMed=16943190; DOI=10.1074/jbc.m603126200;
RA   Tanos B., Pendergast A.M.;
RT   "Abl tyrosine kinase regulates endocytosis of the epidermal growth factor
RT   receptor.";
RL   J. Biol. Chem. 281:32714-32723(2006).
RN   [38]
RP   FUNCTION, AND INTERACTION WITH PSMA7.
RX   PubMed=16678104; DOI=10.1016/j.molcel.2006.04.007;
RA   Liu X., Huang W., Li C., Li P., Yuan J., Li X., Qiu X.B., Ma Q., Cao C.;
RT   "Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit
RT   PSMA7 regulates proteasome degradation.";
RL   Mol. Cell 22:317-327(2006).
RN   [39]
RP   FUNCTION.
RX   PubMed=17306540; DOI=10.1016/j.cub.2007.01.057;
RA   Boyle S.N., Michaud G.A., Schweitzer B., Predki P.F., Koleske A.J.;
RT   "A critical role for cortactin phosphorylation by Abl-family kinases in
RT   PDGF-induced dorsal-wave formation.";
RL   Curr. Biol. 17:445-451(2007).
RN   [40]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH WASF3.
RX   PubMed=17623672; DOI=10.1074/jbc.m701484200;
RA   Sossey-Alaoui K., Li X., Cowell J.K.;
RT   "c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia
RT   formation and cell migration.";
RL   J. Biol. Chem. 282:26257-26265(2007).
RN   [41]
RP   PHOSPHORYLATION AT SER-618 AND SER-619, AND INTERACTION WITH ABI2 AND CRK.
RX   PubMed=18161990; DOI=10.1021/bi701533j;
RA   Jung J.H., Pendergast A.M., Zipfel P.A., Traugh J.A.;
RT   "Phosphorylation of c-Abl by protein kinase Pak2 regulates differential
RT   binding of ABI2 and CRK.";
RL   Biochemistry 47:1094-1104(2008).
RN   [42]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=18328268; DOI=10.1016/j.bbamcr.2008.01.028;
RA   Xiong X., Cui P., Hossain S., Xu R., Warner B., Guo X., An X.,
RA   Debnath A.K., Cowburn D., Kotula L.;
RT   "Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by
RT   phosphopeptides derived from Abi1/Hssh3bp1.";
RL   Biochim. Biophys. Acta 1783:737-747(2008).
RN   [43]
RP   FUNCTION.
RX   PubMed=18945674; DOI=10.1074/jbc.m804543200;
RA   Yogalingam G., Pendergast A.M.;
RT   "Abl kinases regulate autophagy by promoting the trafficking and function
RT   of lysosomal components.";
RL   J. Biol. Chem. 283:35941-35953(2008).
RN   [44]
RP   PHOSPHORYLATION AT TYR-70, AND INTERACTION WITH ABI1.
RX   PubMed=18775435; DOI=10.1016/j.jmb.2008.08.040;
RA   Chen S., O'Reilly L.P., Smithgall T.E., Engen J.R.;
RT   "Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory
RT   interactions within the c-Abl kinase core.";
RL   J. Mol. Biol. 383:414-423(2008).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-569; SER-659;
RP   THR-814; THR-844 AND SER-977, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [46]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; THR-852 AND SER-917, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [47]
RP   REVIEW ON FUNCTION.
RX   PubMed=18182299; DOI=10.1016/j.tibs.2007.10.006;
RA   Backert S., Feller S.M., Wessler S.;
RT   "Emerging roles of Abl family tyrosine kinases in microbial pathogenesis.";
RL   Trends Biochem. Sci. 33:80-90(2008).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [49]
RP   FUNCTION.
RX   PubMed=19891780; DOI=10.1186/1471-2121-10-80;
RA   Fernow I., Tomasovic A., Siehoff-Icking A., Tikkanen R.;
RT   "Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src
RT   kinases.";
RL   BMC Cell Biol. 10:80-80(2009).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [51]
RP   IDENTIFICATION IN A COMPLEX WITH UNC119; ABL2 AND CRK.
RX   PubMed=19381274; DOI=10.1371/journal.pone.0005211;
RA   Vepachedu R., Karim Z., Patel O., Goplen N., Alam R.;
RT   "Unc119 protects from Shigella infection by inhibiting the Abl family
RT   kinases.";
RL   PLoS ONE 4:E5211-E5211(2009).
RN   [52]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-569, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [53]
RP   FUNCTION.
RX   PubMed=20417104; DOI=10.1016/j.cub.2010.03.048;
RA   Michael M., Vehlow A., Navarro C., Krause M.;
RT   "c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of
RT   fibroblasts and axonal morphogenesis.";
RL   Curr. Biol. 20:783-791(2010).
RN   [54]
RP   INTERACTION WITH MYLK AND CTTN.
RX   PubMed=20861316; DOI=10.1091/mbc.e09-10-0876;
RA   Dudek S.M., Chiang E.T., Camp S.M., Guo Y., Zhao J., Brown M.E.,
RA   Singleton P.A., Wang L., Desai A., Arce F.T., Lal R., Van Eyk J.E.,
RA   Imam S.Z., Garcia J.G.N.;
RT   "Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to
RT   regulate endothelial barrier function.";
RL   Mol. Biol. Cell 21:4042-4056(2010).
RN   [55]
RP   REVIEW ON FUNCTION, AND DOMAIN.
RX   PubMed=20841568; DOI=10.1126/scisignal.3139re6;
RA   Colicelli J.;
RT   "ABL tyrosine kinases: evolution of function, regulation, and
RT   specificity.";
RL   Sci. Signal. 3:RE6-RE6(2010).
RN   [56]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [57]
RP   INTERACTION WITH STX17.
RX   PubMed=23006999; DOI=10.1016/j.bbamcr.2012.09.003;
RA   Muppirala M., Gupta V., Swarup G.;
RT   "Tyrosine phosphorylation of a SNARE protein, Syntaxin 17: Implications for
RT   membrane trafficking in the early secretory pathway.";
RL   Biochim. Biophys. Acta 1823:2109-2119(2012).
RN   [58]
RP   FUNCTION, AND INTERACTION WITH NEDD9.
RX   PubMed=22810897; DOI=10.1126/scisignal.2002632;
RA   Gu J.J., Lavau C.P., Pugacheva E., Soderblom E.J., Moseley M.A.,
RA   Pendergast A.M.;
RT   "Abl family kinases modulate T cell-mediated inflammation and chemokine-
RT   induced migration through the adaptor HEF1 and the GTPase Rap1.";
RL   Sci. Signal. 5:ra51-ra51(2012).
RN   [59]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-253; TYR-257; TYR-413;
RP   SER-559; SER-569; SER-620; SER-683; SER-718; THR-751; THR-781; THR-823;
RP   THR-844; THR-852; SER-855 AND SER-917, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [60]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [61]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=28428613; DOI=10.1038/s41598-017-00800-w;
RA   Cobbaut M., Derua R., Doeppler H., Lou H.J., Vandoninck S., Storz P.,
RA   Turk B.E., Seufferlein T., Waelkens E., Janssens V., Van Lint J.;
RT   "Differential regulation of PKD isoforms in oxidative stress conditions
RT   through phosphorylation of a conserved Tyr in the P+1 loop.";
RL   Sci. Rep. 7:887-887(2017).
RN   [62]
RP   STRUCTURE BY NMR OF SH2 DOMAIN.
RX   PubMed=1505033; DOI=10.1016/0092-8674(92)90437-h;
RA   Overduin M., Rios C.B., Mayer B.J., Baltimore D., Cowburn D.;
RT   "Three-dimensional solution structure of the src homology 2 domain of c-
RT   abl.";
RL   Cell 70:697-704(1992).
RN   [63]
RP   STRUCTURE BY NMR OF SH2 DOMAIN.
RX   PubMed=1281542; DOI=10.1073/pnas.89.24.11673;
RA   Overduin M., Mayer B.J., Rios C.B., Baltimore D., Cowburn D.;
RT   "Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR
RT   spectroscopy in solution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:11673-11677(1992).
RN   [64]
RP   3D-STRUCTURE MODELING OF SH3 DOMAIN.
RX   PubMed=7892170; DOI=10.1002/prot.340200302;
RA   Pisabarro M.T., Ortiz A.R., Serrano L., Wade R.C.;
RT   "Homology modeling of the Abl-SH3 domain.";
RL   Proteins 20:203-215(1994).
RN   [65]
RP   STRUCTURE BY NMR OF SH3 DOMAIN.
RX   PubMed=8590002; DOI=10.1016/s0969-2126(01)00243-x;
RA   Gosser Y.Q., Zheng J., Overduin M., Mayer B.J., Cowburn D.;
RT   "The solution structure of Abl SH3, and its relationship to SH2 in the
RT   SH(32) construct.";
RL   Structure 3:1075-1086(1995).
RN   [66]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 64-121.
RX   PubMed=9698566; DOI=10.1006/jmbi.1998.1932;
RA   Pisabarro M.T., Serrano L., Wilmanns M.;
RT   "Crystal structure of the abl-SH3 domain complexed with a designed high-
RT   affinity peptide ligand: implications for SH3-ligand interactions.";
RL   J. Mol. Biol. 281:513-521(1998).
RN   [67]
RP   STRUCTURE BY NMR OF 62-122 IN COMPLEX WITH CRK.
RX   PubMed=12384576; DOI=10.1073/pnas.212518799;
RA   Donaldson L.W., Gish G., Pawson T., Kay L.E., Forman-Kay J.D.;
RT   "Structure of a regulatory complex involving the Abl SH3 domain, the Crk
RT   SH2 domain, and a Crk-derived phosphopeptide.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14053-14058(2002).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (3.42 ANGSTROMS) OF 27-512, MYRISTOYLATION AT GLY-2
RP   (ISOFORM IB), ACTIVITY REGULATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12654251; DOI=10.1016/s0092-8674(03)00194-6;
RA   Nagar B., Hantschel O., Young M.A., Scheffzek K., Veach D., Bornmann W.,
RA   Clarkson B., Superti-Furga G., Kuriyan J.;
RT   "Structural basis for the autoinhibition of c-Abl tyrosine kinase.";
RL   Cell 112:859-871(2003).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 229-513 OF MUTANT PRO-396 IN
RP   COMPLEX WITH INHIBITOR VX-680, FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=16424036; DOI=10.1158/0008-5472.can-05-2788;
RA   Young M.A., Shah N.P., Chao L.H., Seeliger M., Milanov Z.V.,
RA   Biggs W.H. III, Treiber D.K., Patel H.K., Zarrinkar P.P., Lockhart D.J.,
RA   Sawyers C.L., Kuriyan J.;
RT   "Structure of the kinase domain of an imatinib-resistant Abl mutant in
RT   complex with the Aurora kinase inhibitor VX-680.";
RL   Cancer Res. 66:1007-1014(2006).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 38-512, IDENTIFICATION BY MASS
RP   SPECTROMETRY, MYRISTOYLATION AT GLY-2 (ISOFORM IB), PHOSPHORYLATION AT
RP   SER-50, AUTOINHIBITORY MECHANISM, AND ACTIVITY REGULATION.
RX   PubMed=16543148; DOI=10.1016/j.molcel.2006.01.035;
RA   Nagar B., Hantschel O., Seeliger M., Davies J.M., Weis W.I.,
RA   Superti-Furga G., Kuriyan J.;
RT   "Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl
RT   tyrosine kinase.";
RL   Mol. Cell 21:787-798(2006).
RN   [71]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 229-512 IN COMPLEXES WITH
RP   ATP-PEPTIDE CONJUGATE, AND CONFORMATION CHANGES DURING ACTIVATION.
RX   PubMed=16640460; DOI=10.1371/journal.pbio.0040144;
RA   Levinson N.M., Kuchment O., Shen K., Young M.A., Koldobskiy M., Karplus M.,
RA   Cole P.A., Kuriyan J.;
RT   "A Src-like inactive conformation in the abl tyrosine kinase domain.";
RL   PLoS Biol. 4:E144-E144(2006).
RN   [72]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 229-500 IN COMPLEXES WITH IMATINIB
RP   AND WITH THE INHIBITORS NVP-AEG082; NVP-AFN941; NVP-AFG210 AND PD180970.
RX   PubMed=17164530; DOI=10.1107/s0907444906047287;
RA   Cowan-Jacob S.W., Fendrich G., Floersheimer A., Furet P., Liebetanz J.,
RA   Rummel G., Rheinberger P., Centeleghe M., Fabbro D., Manley P.W.;
RT   "Structural biology contributions to the discovery of drugs to treat
RT   chronic myelogenous leukaemia.";
RL   Acta Crystallogr. D 63:80-93(2007).
RN   [73]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 64-121 OF MUTANT ALA-114 IN
RP   COMPLEX WITH PROLINE-RICH PEPTIDE.
RX   PubMed=17452790; DOI=10.1107/s0907444907011109;
RA   Camara-Artigas A., Palencia A., Martinez J.C., Luque I., Gavira J.A.,
RA   Garcia-Ruiz J.M.;
RT   "Crystallization by capillary counter-diffusion and structure determination
RT   of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with
RT   a high-affinity peptide ligand.";
RL   Acta Crystallogr. D 63:646-652(2007).
RN   [74]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 60-121 IN COMPLEX WITH
RP   PROLINE-RICH PEPTIDE P41.
RX   PubMed=19906645; DOI=10.1074/jbc.m109.048033;
RA   Palencia A., Camara-Artigas A., Pisabarro M.T., Martinez J.C., Luque I.;
RT   "Role of interfacial water molecules in proline-rich ligand recognition by
RT   the Src homology 3 domain of Abl.";
RL   J. Biol. Chem. 285:2823-2833(2010).
RN   [75]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 121-232 IN COMPLEX WITH ANTIBODY
RP   MIMIC HA4, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20357770; DOI=10.1038/nsmb.1793;
RA   Wojcik J., Hantschel O., Grebien F., Kaupe I., Bennett K.L., Barkinge J.,
RA   Jones R.B., Koide A., Superti-Furga G., Koide S.;
RT   "A potent and highly specific FN3 monobody inhibitor of the Abl SH2
RT   domain.";
RL   Nat. Struct. Mol. Biol. 17:519-527(2010).
RN   [76]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH NUP214.
RX   PubMed=15361874; DOI=10.1038/ng1425;
RA   Graux C., Cools J., Melotte C., Quentmeier H., Ferrando A., Levine R.,
RA   Vermeesch J.R., Stul M., Dutta B., Boeckx N., Bosly A., Heimann P.,
RA   Uyttebroeck A., Mentens N., Somers R., MacLeod R.A., Drexler H.G.,
RA   Look A.T., Gilliland D.G., Michaux L., Vandenberghe P., Wlodarska I.,
RA   Marynen P., Hagemeijer A.;
RT   "Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute
RT   lymphoblastic leukemia.";
RL   Nat. Genet. 36:1084-1089(2004).
RN   [77]
RP   VARIANTS GLY-47; LYS-166; VAL-706; LEU-810 AND LEU-972.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [78]
RP   INVOLVEMENT IN CHDSKM, VARIANTS CHDSKM CYS-226 AND THR-337, AND
RP   CHARACTERIZATION OF VARIANTS CHDSKM CYS-226 AND THR-337.
RX   PubMed=28288113; DOI=10.1038/ng.3815;
RA   Wang X., Charng W.L., Chen C.A., Rosenfeld J.A., Al Shamsi A.,
RA   Al-Gazali L., McGuire M., Mew N.A., Arnold G.L., Qu C., Ding Y.,
RA   Muzny D.M., Gibbs R.A., Eng C.M., Walkiewicz M., Xia F., Plon S.E.,
RA   Lupski J.R., Schaaf C.P., Yang Y.;
RT   "Germline mutations in ABL1 cause an autosomal dominant syndrome
RT   characterized by congenital heart defects and skeletal malformations.";
RL   Nat. Genet. 49:613-617(2017).
CC   -!- INTERACTION:
CC       P00519-2; P48165: GJA8; NbExp=3; IntAct=EBI-9254597, EBI-17458373;
CC       P00519-2; Q15323: KRT31; NbExp=3; IntAct=EBI-9254597, EBI-948001;
CC       P00519-2; P37840: SNCA; NbExp=5; IntAct=EBI-9254597, EBI-985879;
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane; Lipid-anchor. Note=The
CC       myristoylated c-ABL protein is reported to be nuclear.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=IA;
CC         IsoId=P00519-1; Sequence=Displayed;
CC       Name=IB;
CC         IsoId=P00519-2; Sequence=VSP_004957;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS35165.1; -.
DR   RefSeq; NP_009297.2; NM_007313.2.
DR   ProteomicsDB; 51260; -.
DR   Ensembl; ENST00000372348.7; ENSP00000361423.2; ENSG00000097007.19.
DR   Proteomes; UP000005640; Chromosome 9.
PE   1: Evidence at protein level;
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1149 AA;  124955 MW;  DF9D4512F78FFE52 CRC64;
     MGQQPGKVLG DQRRPSLPAL HFIKGAGKKE SSRHGGPHCN VFVEHEALQR PVASDFEPQG
     LSEAARWNSK ENLLAGPSEN DPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE
     AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR
     SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN
     KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE
     EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL
     YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF
     PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP
     EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGVRGAVST
     LLQAPELPTK TRTSRRAAEH RDTTDVPEMP HSKGQGESDP LDHEPAVSPL LPRKERGPPE
     GGLNEDERLL PKDKKTNLFS ALIKKKKKTA PTPPKRSSSF REMDGQPERR GAGEEEGRDI
     SNGALAFTPL DTADPAKSPK PSNGAGVPNG ALRESGGSGF RSPHLWKKSS TLTSSRLATG
     EEEGGGSSSK RFLRSCSASC VPHGAKDTEW RSVTLPRDLQ STGRQFDSST FGGHKSEKPA
     LPRKRAGENR SDQVTRGTVT PPPRLVKKNE EAADEVFKDI MESSPGSSPP NLTPKPLRRQ
     VTVAPASGLP HKEEAGKGSA LGTPAAAEPV TPTSKAGSGA PGGTSKGPAE ESRVRRHKHS
     SESPGRDKGK LSRLKPAPPP PPAASAGKAG GKPSQSPSQE AAGEAVLGAK TKATSLVDAV
     NSDAAKPSQP GEGLKKPVLP ATPKPQSAKP SGTPISPAPV PSTLPSASSA LAGDQPSSTA
     FIPLISTRVS LRKTRQPPER IASGAITKGV VLDSTEALCL AISRNSEQMA SHSAVLEAGK
     NLYTFCVSYV DSIQQMRNKF AFREAINKLE NNLRELQICP ATAGSGPAAT QDFSKLLSSV
     KEISDIVQR
//
